A Meta-Analysis of Randomized Controlled Trials Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Alone in HER-2-Positive Advanced Breast Cancer

被引：6
|
作者：
Liao, Cun [1 ]
Yin, Fang [1 ]
Huang, Ping [1 ]
Cao, Yunfei [1 ]
Gao, Feng [1 ]
机构：
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Colorectal & Anal Surg, Nanning, Guangxi, Peoples R China
来源：
BREAST JOURNAL | 2011年 / 17卷 / 01期
关键词：
PHASE-II TRIAL; PACLITAXEL; THERAPY;
D O I：
10.1111/j.1524-4741.2010.01034.x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [1] A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer
    Cao, Yunfei
    Tan, Aihua
    Gao, Feng
    Liu, Lidan
    Liao, Cun
    Mo, Zengnan
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (06) : 677 - 685
  • [2] Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials
    Xiao, Yong-Ying
    Zhan, Ping
    Yuan, Dong-Mei
    Liu, Hong-Bing
    Lv, Tang-Feng
    Song, Yong
    Shi, Yi
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (02) : 151 - 159
  • [3] The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis
    Chen, Zhe-Ling
    Shen, Yan-Wei
    Li, Shu-Ting
    Li, Chun-Li
    Zhang, Ling-Xiao
    Yang, Jiao
    Lv, Meng
    Lin, Ya-Yun
    Wang, Xin
    Yang, Jin
    ONCOTARGETS AND THERAPY, 2016, 9 : 3233 - 3247
  • [4] The Efficacy of Neoadjuvant Chemotherapy for HER-2-Positive Locally Advanced Breast Cancer and Survival Analysis
    Zhang, Wei
    Tian, Huan
    Yang, Shi-hong
    ANALYTICAL CELLULAR PATHOLOGY, 2017, 2017
  • [5] Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: A systematic review and meta-analysis
    Valachis, Antonis
    Mauri, Davide
    Polyzos, Nikolaos P.
    Chlouverakis, Grigoris
    Mavroudis, Dimitrios
    Georgoulias, Vassilios
    BREAST, 2011, 20 (06) : 485 - 490
  • [6] Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trials
    Guarneri, V
    Griguolo, G.
    Miglietta, F.
    Conte, P. F.
    Dieci, M., V
    Girardi, F.
    ESMO OPEN, 2022, 7 (02)
  • [7] Phase II Study of Nab-paclitaxel Plus Cyclophosphamide Plus Trastuzumab Neoadjuvant Chemotherapy in Early HER-2-positive Breast Cancer
    Ogino, Misato
    Fujii, Takaaki
    Koibuchi, Yukio
    Nakazawa, Yuko
    Takata, Daisuke
    Shirabe, Ken
    ANTICANCER RESEARCH, 2021, 41 (08) : 3899 - 3904
  • [8] Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients
    Sawaki, Masataka
    Taira, Naruto
    Uemura, Yukari
    Saito, Tsuyoshi
    Baba, Shinichi
    Kobayashi, Kokoro
    Kawashima, Hiroaki
    Tsuneizumi, Michiko
    Sagawa, Noriko
    Bando, Hiroko
    Takahashi, Masato
    Yamaguchi, Miki
    Takashima, Tsutomu
    Nakayama, Takahiro
    Kashiwaba, Masahiro
    Mizuno, Toshiro
    Yamamoto, Yutaka
    Iwata, Hiroji
    Kawahara, Takuya
    Ohashi, Yasuo
    Mukai, Hirofumi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) : 3743 - +
  • [9] Chemotherapy plus Vandetanib or Chemotherapy Alone in Advanced Non-small Cell Lung Cancer: A Meta-analysis of Four Randomised Controlled Trials
    Xiao, Yong-Ying
    Zhan, Ping
    Yuan, Dong-Mei
    Liu, Hong-Bing
    Lv, Tang-Feng
    Shi, Yi
    Song, Yong
    CLINICAL ONCOLOGY, 2013, 25 (01) : E7 - E15
  • [10] PARP inhibitor plus chemotherapy versus chemotherapy alone in patients with triple-negative breast cancer: a systematic review and meta-analysis based on randomized controlled trials
    Li, Chenxi
    Hao, Meiqi
    Fang, Zige
    Ding, Jiatong
    Duan, Sijia
    Yi, Fengming
    Wei, Yiping
    Zhang, Wenxiong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 91 (03) : 203 - 217
12345